B
Blueprint Medicines Corp
F:2L9
Blueprint Medicines Corp
F:2L9
Price:
110.05
EUR
Market Cap:
€6.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Blueprint Medicines Corp
F:2L9
|
US |
|
K
|
Korean Drug Co Ltd
KOSDAQ:014570
|
KR |
|
G
|
GR Silver Mining Ltd
F:GPE
|
CA |
|
C
|
Consolidated Firstfund Capital Corp
XTSX:FFP
|
CA |
|
Q
|
Qualco Group SA
ATHEX:QLCO
|
GR |
Multiples-Based Value
The Multiples-Based Value for Blueprint Medicines Corp (2L9) under the Base Case is hidden EUR. Compared with the current market price of 110.05 EUR, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
2L9 Multiples-Based Value
LOCKED